AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

HEALTH-UGANDA: SECOND HIV/AIDS VACCINE TRIALS UNDER WAY.

Interpress Service

| February 12, 2003 | COPYRIGHT 2003 Global Information Network. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

by Evelyn Kiapi Matsamura

KAMPALA, Feb. 12 (IPS) -- Mutabazi Enos, 33, is a proud man. He was among the 40 Ugandans who volunteered for the first HIV/AIDS vaccine trials in 1999.

Today, Enos stands as an example, proving to skeptics that the vaccine was not harmful.

"The vaccine is not dangerous," he says.

His family was worried about the vaccine, but being a soldier, Enos decided to risk his life by taking part in the trials, known as 'ALVAC Vaccine Phase I'.

Uganda launched the second round of trials on Feb 10. Dr. Ponsiano Kaleebo, who is in charge of the programme, says 50 volunteers will take part in the second trial: DNA MVA Vaccine Phase I.

DNA - deoxyribonucleic acid - carries genetic information in a cell. MVA is the Modified Vaccinia Ankara.

Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA